Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 17 April 1981:
Vol. 212. no. 4492, pp. 340 - 341
DOI: 10.1126/science.7209534

Articles

Science, Vol 212, Issue 4492, 340-341
Copyright © 1981 by American Association for the Advancement of Science


articles

Astatine-211--tellurium radiocolloid cures experimental malignant ascites

WD Bloomer, WH McLaughlin, RD Neirinckx, SJ Adelstein, PR Gordon, TJ Ruth, and AP Wolf

An investigation of the efficacy of astatine-211--tellurium colloid for the treatment of experimental malignant ascites in mice reveals that this alpha-emitting radiocolloid can be curative without causing undue toxicity to normal tissue. By comparison, negatron-emitting phosphorus-32 as colloidal chromic phosphate had no antineoplastic activity. The most compelling explanation for this striking difference is the dense ionization and short range of action associated with alpha-emission. These results have important implications for the development and use of alpha-emitters as radiocolloid therapy for the treatment of human tumors.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
High-Level Production of {alpha}-Particle-Emitting 211At and Preparation of 211At-Labeled Antibodies for Clinical Use.
M. R. Zalutsky, X.-G. Zhao, K. L. Alston, and D. Bigner (2001)
J. Nucl. Med. 42, 1508-1515
   Abstract »    Full Text »    PDF »
Overcoming the Obstacles to Clinical Evaluation of 211At-Labeled Radiopharmaceuticals.
D. S. Wilbur (2001)
J. Nucl. Med. 42, 1516-1518
   Full Text »    PDF »
High and Low Fluences of {{alpha}}-Particles Induce a G1 Checkpoint in Human Diploid Fibroblasts.
E. I. Azzam, S. M. de Toledo, A. J. Waker, and J. B. Little (2000)
Cancer Res. 60, 2623-2631
   Abstract »    Full Text »
Radioimmunotherapy with alpha-particle-emitting immunoconjugates.
R. Macklis, B. Kinsey, A. Kassis, J. Ferrara, R. Atcher, J. Hines, C. Coleman, S. Adelstein, and S. Burakoff (1988)
Science 240, 1024-1026
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)